ANN ARBOR, Mich. — Rick Andrew, director of NSF International Drinking Water Business Development Division, will discuss a new draft standard on emerging compounds/incidental contaminants at WQA Aquatech USA on Thursday, March 20 at 8 a.m., according to a press release.
NSF 401: Drinking water treatment units — Emerging Compounds/Incidental Contaminants, establishes requirements designed to reduce emerging compounds, including pharmaceuticals, personal care products, chemicals and endocrine disrupting compounds such as Bisphenol A (BPA) in water, the release reported.
The standard will focus on claims being made for the reduction of 15 individual compounds including BPA, Meprobamate, Phenytoin, Atenolol, Carbamazepine, TCEP, TCPP, DEET, Metolachlor, Trimethoprim, Ibuprofen, Naproxen, Estrone, Linuron and Nonyl phenol, noted the release.
Read more on NSF here.
This list of contaminants, continued the release, represents pharmaceutical, personal care and endocrine disrupting compounds that have been identified in published studies as occurring in drinking water and the claims are based on testing the actual compound in question.
According to the release, products covered in the standard include several types of drinking water treatment products such as mouth drawn and hand squeezed sports bottle type filtration systems, point-of-use reverse osmosis systems and traditional filtration systems.
